DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,112,000 | -52.7% | 700,000 | -12.5% | 0.32% | -47.9% |
| Q2 2021 | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% |
| Q1 2021 | $20,456,000 | +85.7% | 800,000 | +60.0% | 0.36% | -15.3% |
| Q4 2019 | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| Q3 2019 | $14,360,000 | -8.8% | 1,000,000 | 0.0% | 0.58% | -9.6% |
| Q2 2019 | $15,750,000 | +9.8% | 1,000,000 | +2.1% | 0.64% | +8.7% |
| Q1 2019 | $14,346,000 | +155.6% | 979,275 | +86.5% | 0.59% | +181.7% |
| Q4 2018 | $5,612,000 | -13.5% | 525,000 | +23.5% | 0.21% | +23.1% |
| Q3 2018 | $6,486,000 | +24.6% | 425,000 | 0.0% | 0.17% | +52.3% |
| Q2 2018 | $5,206,000 | +28.1% | 425,000 | 0.0% | 0.11% | +117.6% |
| Q1 2018 | $4,063,000 | – | 425,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |